4 reports

  • offers a cure for esophagus cancer if the cancer has not spread beyond the esophagus.
  • Lung Transplant Rejection - Companies Involved in Therapeutics Development

Lung Transplant Rejection - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Lung Transplant Rejection - Pipeline Review, H1 2018, provides an overview of the Lung Transplant Rejection (Immunology) pipeline landscape. Lung...

  • Lung Transplant
  • Therapy
  • Transplantation
  • United States
  • Kamada Ltd.
  • LUNG TRANSPLANT REJECTION - PIPELINE BY TXCELL SA, H2 2018
  • LUNG TRANSPLANT REJECTION - PIPELINE BY QUARK PHARMACEUTICALS INC, H2 2018

Following one year of AAT treatment, there will be a one-year follow-up.

  • General Medicine And Specialty Medicine
  • Lung Transplant
  • Therapy
  • Transplantation
  • United States
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Lung Transplant
  • World
  • Novartis AG
  • Lung Transplantation - Product Development Milestones

Transthoracic esophagectomy is a surgical procedure that potentially offers a cure for esophagus cancer if the cancer has not spread beyond the esophagus.

  • Lung Transplant
  • United States
  • Company Operations
  • Product Initiative
  • Proteo Biotech AG